Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events

• मुख्य लेखकों: Long He (लेखक), Qiuyu Li (लेखक), Yongfeng Yang (लेखक), Jiahao Li (लेखक), Wei Luo (लेखक), Yilan Huang (लेखक), Xiaoyan Zhong (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Aims: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are employed extensively in the management of type 2 diabetes and obesity. However, there is a paucity of real-world data on their safety and tolerability for metabolic and nutritional adverse events in large sample populations. This study...